{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:27Z","timestamp":1777984347426,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07900-0","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:46:20Z","timestamp":1772084780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct gut virome profiles are associated with response to anti-PD-1 therapy in non-small cell lung cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhuo","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guorui","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghaotian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiulong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"1","key":"7900_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"7900_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamaoncol.2024.0057","volume":"10","author":"M Sorin","year":"2024","unstructured":"Sorin M, et al. Neoadjuvant chemoimmunotherapy for NSCLC: a systematic review and meta-analysis. JAMA Oncol. 2024;10(5):621\u201333.","journal-title":"JAMA Oncol"},{"issue":"1","key":"7900_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.32471\/exp-oncology.2312-8852.vol-44-no-1.17411","volume":"44","author":"M Kumar","year":"2022","unstructured":"Kumar M, Sarkar AJEO. Current therapeutic strategies and challenges in NSCLC treatment: a comprehensive review. Exp Oncol. 2022;44(1):7\u201316.","journal-title":"Exp Oncol"},{"issue":"3","key":"7900_CR4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/resp.12490","volume":"20","author":"N Barr Kumarakulasinghe","year":"2015","unstructured":"Barr Kumarakulasinghe N, Zanwijk NV, Soo RAJR. Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC). Respirology. 2015;20(3):370\u201378.","journal-title":"Respirology"},{"issue":"5","key":"7900_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1055\/s-0036-1592298","volume":"37","author":"KA Marrone","year":"2016","unstructured":"Marrone KA, Naidoo J, Brahmer JR. Immunotherapy for lung cancer: no longer an abstract concept. Semin Respir Crit Care Med. 2016;37(5):771\u201382.","journal-title":"Semin Respir Crit Care Med"},{"issue":"10048","key":"7900_CR6","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(16)31473-8","volume":"388","author":"FR Hirsch","year":"2016","unstructured":"Hirsch FR, et al. New and emerging targeted treatments in advanced non-small-cell lung cancer. Lancet. 2016;388(10048):1012\u201324.","journal-title":"Lancet"},{"key":"7900_CR7","doi-asserted-by":"crossref","unstructured":"Zago G, et al. New targeted treatments for non-small-cell lung cancer-role of nivolumab. Biologics. 2016;103\u201317.","DOI":"10.2147\/BTT.S87878"},{"key":"7900_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ctrv.2017.10.002","volume":"62","author":"S Peters","year":"2018","unstructured":"Peters S, Kerr KM, Stahel RJCTR. PD-1 blockade in advanced NSCLC: a focus on pembrolizumab. Cancer Treat Rev. 2018;62:39\u201349.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"7900_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40164-021-00211-8","volume":"10","author":"M Niu","year":"2021","unstructured":"Niu M, et al. Predictive biomarkers of anti-PD-1\/PD-L1 therapy in NSCLC. Exp Hematol Oncol. 2021;10(1):18.","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"7900_CR10","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.21037\/tlcr-20-1019","volume":"10","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review. Transl Lung Cancer Res. 2021;10(2):1029.","journal-title":"Transl Lung Cancer Res"},{"issue":"11","key":"7900_CR11","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1001\/jamaoncol.2018.3676","volume":"4","author":"R Ferrara","year":"2018","unstructured":"Ferrara R, et al. Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors or with single-agent chemotherapy. JAMA Oncol. 2018;4(11):1543\u201352.","journal-title":"JAMA Oncol"},{"issue":"6264","key":"7900_CR12","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350(6264):1084\u201389.","journal-title":"Science"},{"issue":"6371","key":"7900_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97\u2013103.","journal-title":"Science"},{"issue":"2","key":"7900_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","volume":"28","author":"L Derosa","year":"2022","unstructured":"Derosa L, et al. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med. 2022;28(2):315\u201324.","journal-title":"Nat Med"},{"key":"7900_CR15","first-page":"7883945","volume":"1","author":"NA Clinton","year":"2022","unstructured":"Clinton NA, et al. Crosstalk between the Intestinal virome and other components of the microbiota, and its effect on Intestinal mucosal response and diseases. J Immunol Res. 2022;1:7883945.","journal-title":"J Immunol Res"},{"issue":"12","key":"7900_CR16","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3390\/microorganisms9122538","volume":"9","author":"F Broecker","year":"2021","unstructured":"Broecker F, Moelling K. The roles of the virome in cancer. Microorganisms. 2021;9(12):2538.","journal-title":"Microorganisms"},{"key":"7900_CR17","doi-asserted-by":"publisher","first-page":"1378900","DOI":"10.3389\/fgene.2024.1378900","volume":"15","author":"E Iwan","year":"2024","unstructured":"Iwan E, et al. Gut resistome of NSCLC patients treated with immunotherapy. Front Genet. 2024;15:1378900.","journal-title":"Front Genet"},{"issue":"2","key":"7900_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"key":"7900_CR19","doi-asserted-by":"crossref","unstructured":"Chen S, et al. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884\u201390.","DOI":"10.1093\/bioinformatics\/bty560"},{"issue":"4","key":"7900_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2. Nat Methods. 2012;9(4):357\u201359.","journal-title":"Nat Methods"},{"key":"7900_CR21","doi-asserted-by":"crossref","unstructured":"Yan Q, et al. The Chinese gut virus catalogue reveals gut virome diversity and disease-related viral signatures. Genome Med. 17, 30 (2025).","DOI":"10.1186\/s13073-025-01460-6"},{"issue":"1","key":"7900_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nmeth.3176","volume":"12","author":"B Buchfink","year":"2015","unstructured":"Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. Nat Methods. 2015;12(1):59\u201360.","journal-title":"Nat Methods"},{"key":"7900_CR23","doi-asserted-by":"crossref","unstructured":"Kanehisa M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361.","DOI":"10.1093\/nar\/gkw1092"},{"issue":"11","key":"7900_CR24","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/s41587-023-01688-w","volume":"41","author":"A Blanco-M\u00edguez","year":"2023","unstructured":"Blanco-M\u00edguez A, et al. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. Nat Biotechnol. 2023;41(11):1633\u201344.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"7900_CR25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1654-1103.2003.tb02228.x","volume":"14","author":"P Dixon","year":"2003","unstructured":"Dixon P. VEGAN, a package of R functions for community ecology. J Veg Sci. 2003;14(6):927\u201330.","journal-title":"J Veg Sci"},{"key":"7900_CR26","doi-asserted-by":"crossref","unstructured":"Mallick H, et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol. 2021;17(11):e1009442.","DOI":"10.1371\/journal.pcbi.1009442"},{"issue":"10","key":"7900_CR27","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/2326-6066.CIR-20-0196","volume":"8","author":"T Hakozaki","year":"2020","unstructured":"Hakozaki T, et al. The gut microbiome associates with immune checkpoint inhibition outcomes in patients with advanced non-small cell lung cancer. Cancer Immunol Res. 2020;8(10):1243\u201350.","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"7900_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.21037\/tlcr.2019.10.23","volume":"8","author":"Y Katayama","year":"2019","unstructured":"Katayama Y, et al. The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer. Transl Lung Cancer Res. 2019;8(6):847\u201353.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"7900_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13568-022-01428-4","volume":"12","author":"A Grenda","year":"2022","unstructured":"Grenda A, et al. Presence of akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer. AMB Express. 2022;12(1):86.","journal-title":"AMB Express"},{"key":"7900_CR30","doi-asserted-by":"crossref","unstructured":"Chica Cardenas LA, et al. Gut virome dynamics: from commensal to critical player in health and disease. Nat Rev Gastroenterol Hepatol. 2025;1\u201319.","DOI":"10.1038\/s41575-025-01134-z"},{"issue":"1","key":"7900_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41522-025-00785-9","volume":"11","author":"Y Yang","year":"2025","unstructured":"Yang Y, et al. Gut microbiota and SCFAs improve the treatment efficacy of chemotherapy and immunotherapy in NSCLC. NPJ Biofilms Microbiomes. 2025;11(1):146.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"11","key":"7900_CR32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0966-842X(02)02459-9","volume":"10","author":"EF Boyd","year":"2002","unstructured":"Boyd EF, Br\u00fcssow H. Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involved. Trends Microbiol. 2002;10(11):521\u201329.","journal-title":"Trends Microbiol"},{"key":"7900_CR33","doi-asserted-by":"crossref","unstructured":"Byrd AL, et al. Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers. J Exp Med. 2021;218(1).","DOI":"10.1084\/jem.20200606"},{"key":"7900_CR34","doi-asserted-by":"crossref","unstructured":"Xu H, et al. Efficacy of intestinal microorganisms on immunotherapy of non-small cell lung cancer. Heliyon. 2024;10(9).","DOI":"10.1016\/j.heliyon.2024.e29899"},{"issue":"6","key":"7900_CR35","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1093\/annonc\/mdx108","volume":"28","author":"N Chaput","year":"2017","unstructured":"Chaput N, et al. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann Oncol. 2017;28(6):1368\u201379.","journal-title":"Ann Oncol"},{"issue":"10","key":"7900_CR36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1158\/2326-6066.CIR-19-1014","volume":"8","author":"Z Peng","year":"2020","unstructured":"Peng Z, et al. The gut microbiome is associated with clinical response to anti-PD-1\/PD-L1 immunotherapy in gastrointestinal cancer. Cancer Immunol Res. 2020;8(10):1251\u201361.","journal-title":"Cancer Immunol Res"},{"key":"7900_CR37","doi-asserted-by":"crossref","unstructured":"Mesnage S, Foster SJ. Chapter 261 - N-Acetylmuramoyl-l-alanine amidase. In: Handbook of proteolytic enzymes. Academic Press, Academic Press; 2025. p. 1671\u201377.","DOI":"10.1016\/B978-0-443-28849-4.00262-9"},{"issue":"5","key":"7900_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12032-022-01676-1","volume":"39","author":"J Chen","year":"2022","unstructured":"Chen J, et al. ENO3 promotes colorectal cancer progression by enhancing cell glycolysis. Med Oncol. 2022;39(5):80.","journal-title":"Med Oncol"},{"issue":"7","key":"7900_CR39","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1007\/s12094-023-03114-8","volume":"25","author":"CK Huang","year":"2023","unstructured":"Huang CK, et al. ENO1 promotes immunosuppression and tumor growth in pancreatic cancer. Clin Transl Oncol. 2023;25(7):2250\u201364.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"7900_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13073-022-01037-7","volume":"14","author":"RC Newsome","year":"2022","unstructured":"Newsome RC, et al. Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohort. Genome Med. 2022;14(1):35.","journal-title":"Genome Med"},{"issue":"6575","key":"7900_CR41","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.aaz7015","volume":"374","author":"CN Spencer","year":"2021","unstructured":"Spencer CN, et al. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021;374(6575):1632\u201340.","journal-title":"Science"},{"key":"7900_CR42","doi-asserted-by":"crossref","unstructured":"Hillman ET, et al. Comparative genomics of the genus Roseburia reveals divergent biosynthetic pathways that may influence colonic competition among species. Microb. Genomics. 2020;6(7):e000399.","DOI":"10.1099\/mgen.0.000399"},{"issue":"11","key":"7900_CR43","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1136\/gutjnl-2023-330291","volume":"72","author":"X Kang","year":"2023","unstructured":"Kang X, et al. Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells. Gut. 2023;72(11):2112\u201322.","journal-title":"Gut"},{"issue":"2","key":"7900_CR44","doi-asserted-by":"publisher","first-page":"2249143","DOI":"10.1080\/19490976.2023.2249143","volume":"15","author":"X Zhu","year":"2023","unstructured":"Zhu X, et al. Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell. Gut Microbes. 2023;15(2):2249143.","journal-title":"Gut Microbes"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07900-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:57:57Z","timestamp":1775033877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07900-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7900"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07900-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8256866\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study involves secondary analysis of publicly available data hence no ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have agreed to this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"461"}}